Skip to content

Comprehensive Ability Assessment and Non-pharmacological Cognitive Intervention in Older Adults

Comprehensive Geriatric Assessment and Non-pharmacological Intervention for Cognitive Function in Older Adults

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600129215
Enrollment
Unknown
Registered
2026-08-01
Start date
2026-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive impairment

Interventions

Cognitive training intervention group:Standardized cognitive training program twice a week for 45 minutes each session over 12 weeks, including training in memory, attention, language ability, and exe
Nursing home routine care control group:Receive routine nursing care and health education in nursing homes and communities, with no additional cognitive training or comprehensive intervention services

Sponsors

Hangzhou City University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >=60 years and living long-term in a nursing home; 2. Scores on the Mini-Mental State Examination (MMSE) meet the diagnostic criteria for mild-to-moderate cognitive impairment; 3. No severe hearing or visual impairment, and able to cooperate with assessments and interventions; 4. Voluntarily participating in this study and signing the informed consent form. 5. Be of sound mind and possess basic communication skills; 6. Be able to complete assessment scales and intervention activities independently or with assistance.

Exclusion criteria

Exclusion criteria: 1. Those clinically diagnosed with severe dementia or other serious neuropsychiatric disorders; 2. Patients with severe organ failure (e.g., heart, liver, kidney) or malignant tumors; 3. Those with severe motor dysfunction and unable to participate in non-pharmacological intervention activities; 4. Those currently participating in other cognitive intervention studies or having received similar interventions recently; 5. Those judged by the researchers to have other conditions unsuitable for participating in this study.

Design outcomes

Primary

MeasureTime frame
Cognitive function level;

Secondary

MeasureTime frame
Quality of life in Alzheimer's disease; Activities of daily living (ADL);Neuropsychiatric symptoms;Loneliness level; Frailty status;Anxiety symptoms;Sleep quality;Happiness level;Depressive symptoms;

Countries

China

Contacts

Public ContactWang Qiaoqiao

Hangzhou City University

wangqq@hzcu.edu.cn+86 189 6716 4485

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026